Antibiotic Resistance Mechanisms of Escherichia coli Isolates from Urinary Specimens
2
조회
0
다운로드
9
인용
0
참고문헌
키워드
초록
Background : This study was designed to characterize urinary isolates of Escherichia coli that produce extended-spectrum β-lactamases (ESBLs) and to determine the prevalence of other antimicrobial resistance genes. Methods : A total of 264 non-duplicate clinical isolates of E. coli were recovered from urine specimens in a tertiary-care hospital in Busan in 2005. Antimicrobial susceptibility was determined by disk diffusion and agar dilution methods, ESBL production was confirmed using the double-disk synergy (DDS) test, and antimicrobial resistance genes were detected by direct sequencing of PCR amplification products. E. coli isolates were classified into four phylogenetic biotypes according to the presence of chuA, yjaA, and TSPE4. Results : DDS testing detected ESBLs in 27 (10.2%) of the 264 isolates. The most common type of ESBL was CTX-M-15 (N=14), followed by CTX-M-3 (N=8) and CTX-M-14 (N=6). All of the ESBLproducing isolates were resistant to ciprofloxacin. PCR experiments detected genes encoding DHA- 1 and CMY-10 AmpC β-lactamases in one and two isolates, respectively. Also isolated were 5 isolates harboring 16S rRNA methylases, 2 isolates harboring Qnr, and 19 isolates harboring AAC(6’)- Ib-cr. Most ESBL-producing isolates clustered within phylogenetic groups B2 (N=14) and D (N=7). Conclusion : CTX-M enzymes were the dominant type of ESBLs in urinary isolates of E. coli, and ESBL-producing isolates frequently contained other antimicrobial resistance genes. More than half of the urinary E. coli isolates harboring CTX-M enzymes were within the phylogenetic group B2.
Abstract
Background : This study was designed to characterize urinary isolates of Escherichia coli that produce extended-spectrum β-lactamases (ESBLs) and to determine the prevalence of other antimicrobial resistance genes. Methods : A total of 264 non-duplicate clinical isolates of E. coli were recovered from urine specimens in a tertiary-care hospital in Busan in 2005. Antimicrobial susceptibility was determined by disk diffusion and agar dilution methods, ESBL production was confirmed using the double-disk synergy (DDS) test, and antimicrobial resistance genes were detected by direct sequencing of PCR amplification products. E. coli isolates were classified into four phylogenetic biotypes according to the presence of chuA, yjaA, and TSPE4. Results : DDS testing detected ESBLs in 27 (10.2%) of the 264 isolates. The most common type of ESBL was CTX-M-15 (N=14), followed by CTX-M-3 (N=8) and CTX-M-14 (N=6). All of the ESBLproducing isolates were resistant to ciprofloxacin. PCR experiments detected genes encoding DHA- 1 and CMY-10 AmpC β-lactamases in one and two isolates, respectively. Also isolated were 5 isolates harboring 16S rRNA methylases, 2 isolates harboring Qnr, and 19 isolates harboring AAC(6’)- Ib-cr. Most ESBL-producing isolates clustered within phylogenetic groups B2 (N=14) and D (N=7). Conclusion : CTX-M enzymes were the dominant type of ESBLs in urinary isolates of E. coli, and ESBL-producing isolates frequently contained other antimicrobial resistance genes. More than half of the urinary E. coli isolates harboring CTX-M enzymes were within the phylogenetic group B2.
참고문헌 (31)
- Piatti G, "Virulence factors in urinary Escherichia coli strains: phylogenetic background and quinolone and fluoroquinolone resistance", J Clin Microbiol, 46, pp.480~487 (2008)
- Bonnet R, "Growing group of extended-spectrum β-lactamases: the CTX-M enzymes", Antimicrob Agents Chemother, 48, pp.1~14 (2004)
- Kim J, "Occurrence of CTX-M-3, CTXM-15, CTX-M-14, and CTX-M-9 extended-spectrum β-lactamases in Enterobacteriaceae clinical isolates in Korea", Antimicrob Agents Chemother, 46, pp.1572~1575 (2005)
- Rossolini GM, "The spread of CTX-Mtype extended-spectrum β-lactamases", Clin Microbiol Infect, 14, pp.33~41 (2008)
- 배일권, "CTX-M-12, PER-1 및 OXA-30 β-Lactamase 생성 Klebsiella pneumoniae의 출현", 대한임상미생물학회지, 9(2), pp.102~109 (2006), 대한임상미생물학회
- Philippon A, "Plasmid-determined AmpC-type β-lactamases", Antimicrob Agents Chemother, 46, pp.1~11 (2002)
- Lee K, "Prevalence of plasmid-mediated AmpC β-lactamases in Escherichia coli and Klebsiella pneumoniae in Korea", Microb Drug Resist, 12, pp.44~49 (2006)
- Hooper DC, "Mechanisms of fluoroquinolone resistance", Drug Resist Updat, 2, pp.38~55 (1999)
- Herzer PJ, "Phylogenetic distribution of branched RNA-linked multicopy single-stranded DNA among natural isolates of Escherichia coli", J Bacteriol, 172, pp.6175~6181 (1990)
- Jeong SH, "Molecular characterization of extended-spectrum beta-lactamases produced by clinical isolates of Klebsiella pneumoniae and Escherichia coli from a Korean nationwide survey", J Clin Microbiol, 42, pp.2902~2906 (2004)
- Jeong JY, "Detection of qnr in clinical isolates of Escherichia coli from Korea", Antimicrob Agents Chemother, 49, pp.2522~2524 (2005)
- Jeong SH, "Investigation of extended-spectrum β-lactamases produced by clinical isolates of Klebsiella pneumoniae and Escherichia coli in Korea", Lett Appl Microbiol, 39, pp.41~47 (2004)
- Magnet S, "Molecular insights into aminoglycoside action and resistance", Chem Rev, 105, pp.477~498 (2005)
- Doi Y, "16S ribosomal RNA methylation: emerging resistance mechanism against aminoglycosides", Clin Infect Dis, 45, pp.88~94 (2007)
- Baudry PJ, "Comparison of antimicrobial resistance profiles among extended-spectrum β-lactamase-producing and acquired AmpC β-lactamase-producing Escherichia coli isolates from Canadian intensive care units", Antimicrob Agents Chemother, 52, pp.1846~1849 (2008)
- Clinical and Laboratory Standards Institute, "Performance standards for antimicrobial susceptibility testing; seventeenth informational supplement: Approved Standard M100-S17, Wayne, PA: Clinical Laboratory Standards Institute", ~ (2007)
- Sambrook J, "Molecular cloning: a laboratory manual. 2nd ed" (1989), Cold Spring Harbor Laboratory Press
- Ryoo NH, "Dissemination of SHV-12 and CTX-M-type extended-spectrum beta-lactamases among clinical isolates of Escherichia coli and Klebsiella pneumoniae and emergence of GES-3 in Korea", J Antimicrob Chemother, 56, pp.698~702 (2005)
- Song W, "Increasing trend in the prevalence of plasmid-mediated AmpC beta-lactamases in Enterobacteriaceae lacking chromosomal ampC gene at a Korean university hospital from 2002 to 2004", Diagn Microbiol Infect Dis, 55, pp.219~224 (2006)
- Cattoir V, "Multiplex PCR for detection of plasmid-mediated quinolone resistance qnr genes in ESBL-producing enterobacterial isolates", J Antimicrob Chemother, 60, pp.394~397 (2007)
- Fihman V, "Appearance of aac(6’)-Ib-cr gene among extended-spectrum beta-lactamase-producing Enterobacteriaceae in a French hospital", J Infect, 56, pp.454~459 (2008)
- Fritsche TR, "Detection of methyltransferases conferring high-level resistance to aminoglycosides in Enterobacteriaceae from Europe, North America, and Latin America", Antimicrob Agents Chemother, 52, pp.1843~1845 (2008)
- Clermont O, "Rapid and simple determination of the Escherichia coli phylogenetic group", Appl Environ Microbiol, 66, pp.4555~4558 (2000)
- Akram M, "Etiology and antibiotic resistance patterns of community-acquired urinary tract infections in J N M C Hospital Aligarh, India", Ann Clin Microbiol Antimicrob, 6, pp.4~10 (2007)
- Mazzei T, "Pharmacokinetic and pharmacodynamic aspects of antimicrobial agents for the treatment of uncomplicated urinary tract infections", Int J Antimicrob Agents, 28, pp.S35~S41 (2006)
- 고지선, "대전지역에서 분리된 Escherichia coli 와 Klebsiella pneumoniae 의Extended-Spectrum -lactamase 생성 현황", The Korean Journal of Laboratory Medicine, 27(5), pp.344~350 (2007), 대한진단검사의학회
- Hong SG, "Prevalence and diversity of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates in Korea", Korean J Clin Microbiol, 6, pp.149~155 (2003)
- Pitout JD, "Emergence of Enterobacteriaceae producing extended-spectrum β-lactamases (ESBLs) in the community", J Antimicrob Chemother, 56, pp.52~59 (2005)
- Johnson JR, "Phylogenetic distribution of extraintestinal virulence-associated traits in Escherichia coli", J Infect Dis, 183, pp.78~88 (2001)
- Johnson JR, "Phylogenetic origin and virulence genotype in relation to resistance to fluoroquinolones and", or extended-spectrum cephalosporins and cephamycins among Escherichia coli isolates from animals and humans, 2003, pp.188, 759~768
- Pitout JD, "Virulence factors of Escherichia coli isolates that produce CTX-M-type extended-spectrum β-lactamases", Antimicrob Agents Chemother, 49, pp.4667~4670 (2005)